Q3FY17 Results : Granules India
Bhagyashree Vivarekar / 30 Jan 2017
The company reported a PAT figure of Rs 39.06 crore which represents a sequential QoQ decline of 4.32 per cent and a YoY increase of 33.75 per cent.
Granules India reported its results for the quarter ended December 31.
Total sales for this quarter, Q3FY17, came in at Rs 359.73 crore. This represents a 1.12 per cent sequential decline and 10.69 per cent YoY increase.
The operating profit (EBIT) for the recently concluded quarter amounted to Rs 169.81 crore and the EBIT margin stood at 47.2 per cent.
The company reported a PAT figure of Rs 39.06 crore which represents a sequential QoQ decline of 4.32 per cent and a YoY increase of 33.75 per cent.
Granules India Limited is an India-based pharmaceutical company. The company operates in integrated pharmaceutical business segment. It manufactures active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.